|
|
 Stage 3 and 4 CKDPresented by: Leonard Stern, MD, FACP, FASNAssociate Clinical Professor of Medicine
Columbia University College of Physicians and Surgeons Medical Director, Columbia University Dialysis Center, Director of Peritoneal Dialysis, New York Presbyterian Hospital/Columbia University Medical Center, New York, New York Dr. Stern discusses new information regarding vascular calcification in CKD patients, and examines the prevalence and mechanisms for hypertension in CKD patients. He also informs participants how to recognize phosphorous disorders in CKD and therapies to correct phosphatemia.Beyond PTH: VDR Activation and Cardio-Renal OutcomesPresented by: Lavinia A. Negrea, MDAssistant Professor of Medicine, Division of Nephrology
Case Western Reserve University School of Medicine Staff Nephrologist University Hospitals of Cleveland, Cleveland, Ohio Dr. Negrea discusses the interaction of vitamin D intake and metabolic syndrome, and examines the mechanisms and proteins involved in atherosclerosis in hypertensive CKD patients. She also reviews current animal studies that examine cardiovascular risk factors in CKD.SHPT Treatment OptionsPresented by: Ali Abu-Alfa, MD, FASNAssociate Professor of Medicine, Director of Clinical Trials
Director, Peritoneal Dialysis Program
Associate Medical Director for Outpatient Dialysis
Yale School of Medicine, Yale University, New Haven, Connecticut Dr. Abu-Alfa discusses the interaction of cardiovascular disease and chronic kidney disease. He reviews the incidence of vitamin D deficiency, and explores the role of vitamin D in vascular structure and calcification, anemia, diabetes, and osteodystrophy. In addition, Dr. Abu-Alfa discusss therapy for SHPT involving selective vitamin D receptor activators, calcimimetics, and phosphorus binders.CKD SurvivalPresented by: Robert Geronemus, MDSouth Florida Nephrology Associates Private Practice Dr. Geronemus presents data on cardiovascular risk factors and their association with chronic kidney disease. He discusses the implications of cardiovascular disease and predictors of mortality in chronic kidney disease patients. Dr. Geronemus examines the role of vitamin D and nutrition in dialysis patients, as well as discussing anemia that occurs in these patients.
|
 |